N/A
N=38
Mobile Health (mHealth) Nutrition Intervention for Children With Autism Spectrum Disorder
Diet Modification
Bottom Line
View on ClinicalTrials.gov: NCT03424811 ↗Enrolled (actual)
38
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcome: Primary: 3-month Fruit and Vegetable Intake — 2.16; 3.01 Servings per day
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Mobile Health Intervention (Device)
- Age
- Pediatric · 6+ yrs
- Sex
- All
- Sponsor
- University of Pennsylvania
- Primary completion
- Aug 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY 3-month Fruit and Vegetable Intake |
2.16; 3.01 | — |
| PRIMARY 3-month Snack Intake |
420.8; 385.7 | — |
| PRIMARY 3-month Sugar-sweetened Beverage Intake |
7.6; 7.3 | — |
| SECONDARY Evaluation of mHealth Intervention - User Evaluation |
4; 2 | — |
| SECONDARY Evaluation of mHealth Intervention - Technology Engagement |
7; 4 | — |
Summary
The high prevalence of mealtime difficulties and obesity among children with autism spectrum disorder (ASD) calls for new and innovative ways to promote healthy eating and weight development in this population. This project aims to develop and test an interactive mobile health (mHealth) nutrition intervention, which incorporates core behavior change strategies that have been empirically tested in family-based nutrition research and behavioral interventions with children with ASD. The feasibility and efficacy of this mHealth intervention to improve dietary outcomes in children with ASD will be tested in a proof-of-concept randomized controlled trial.
Eligibility Criteria
Inclusion Criteria
- 6 to 10 years;
- fluent in English;
- have an ASD diagnosis;
- cognitive skills within average (or higher) range with IQ ≥ 80;
- above or standardized receptive language scores.
Exclusion Criteria
- moderate-severe hearing/visual or motor impairment;
- taking antipsychotic medications;
- on special diet;
- are underweight (BMI-for-age < 5th percentile).
Data sourced from ClinicalTrials.gov (NCT03424811). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.